These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 7554727

  • 1. Occurrence of islet cell reactive autoantibodies in diabetes-prone BB/OK rats is not associated with the onset of diabetes: a cross-sectional study of BB rats and their diabetes-resistant congenic strains.
    Schlosser M, Ziegler B, Augstein P, Klöting I, Ziegler M.
    Diabetes Res; 1994; 26(2):67-77. PubMed ID: 7554727
    [Abstract] [Full Text] [Related]

  • 2. Autoantibodies to glutamate decarboxylase detected in diabetes-prone BB/OK rats do not distinguish onset of diabetes.
    Ziegler M, Schlosser M, Hamann J, Vieregge P, Lühder F, Klöting I, Ziegler B.
    Exp Clin Endocrinol; 1994; 102(2):98-103. PubMed ID: 8056059
    [Abstract] [Full Text] [Related]

  • 3. Detection of antibodies against both isoforms of glutamate decarboxylase in BB/OK rats by western blotting and immuno trapping enzyme activity assay.
    Lühder F, Woltanski KP, Hamann J, Klöting I, Ziegler B, Ziegler M.
    Diabetes Res; 1992; 20(4):97-107. PubMed ID: 1345008
    [Abstract] [Full Text] [Related]

  • 4. Early appearance of complement-dependent antibody mediated cytotoxicity (C'AMC) to islet cells in serum of diabetes-prone BB/OK rats.
    Hehmke B, Schröder D, Klöting I.
    Diabetes Res; 1990 Apr; 13(4):183-6. PubMed ID: 2134210
    [Abstract] [Full Text] [Related]

  • 5. Detection and time course of humoral-mediated cytotoxicity to different cell types in diabetes-prone BB/OK rats.
    Schröder D, Hehmke B, Klöting I, Schmidt S.
    Diabetes Res; 1991 Jun; 17(2):81-91. PubMed ID: 1817815
    [Abstract] [Full Text] [Related]

  • 6. Congenic diabetes-prone BB.Sa and BB.Xs rats differ from their progenitor strain BB/OK in frequency and severity of insulin-dependent diabetes mellitus.
    van den Brandt J, Kovács P, Klöting I.
    Biochem Biophys Res Commun; 1999 Oct 05; 263(3):843-7. PubMed ID: 10512768
    [Abstract] [Full Text] [Related]

  • 7. Complement-dependent antibody-mediated cytotoxicity (C'AMC) to pancreatic islet cells in the spontaneously diabetic BB/OK rat: interference from cell-bound and soluble inhibitors.
    Hehmke B, Schröder D, Klöting I, Kohnert KD.
    J Clin Lab Immunol; 1991 Jun 05; 35(2):71-81. PubMed ID: 1668761
    [Abstract] [Full Text] [Related]

  • 8. Immunological and beta-cell-specific characteristics of diabetes-prone BB/OK rats and their congenic derivatives--a comparative study.
    Schröder D, Klötting I, Hehmke B, Schmidt S.
    Diabetes Res; 1992 Jun 05; 20(1):21-31. PubMed ID: 1344999
    [Abstract] [Full Text] [Related]

  • 9. Complement-dependent antibody-mediated cytotoxicity in the spontaneously diabetic BB/OK rat: association with beta cell volume density.
    Hehmke B, Lucke S, Schröder D, Klöting I, Kohnert KD.
    Eur J Immunol; 1990 May 05; 20(5):1091-6. PubMed ID: 2192902
    [Abstract] [Full Text] [Related]

  • 10. Apoptosis and disease progression in the spontaneously diabetic BB/S rat.
    Lally FJ, Ratcliff H, Bone AJ.
    Diabetologia; 2001 Mar 05; 44(3):320-4. PubMed ID: 11317663
    [Abstract] [Full Text] [Related]

  • 11. Antibodies to ICA512/IA-2 in rodent models of IDDM.
    Myers MA, Laks MR, Feeney SJ, Mandel TE, Koulmanda M, Bone A, Barley J, Rowley MJ, Mackay IR.
    J Autoimmun; 1998 Jun 05; 11(3):265-72. PubMed ID: 9693975
    [Abstract] [Full Text] [Related]

  • 12. Studies on the correlation between the presence of cytotoxic islet cell surface antibody and the incidence of overt diabetes in BB rats.
    Tanguay KE, Yoon JW, Hart DA.
    Diabetes Res; 1988 Aug 05; 8(4):171-5. PubMed ID: 3069281
    [Abstract] [Full Text] [Related]

  • 13. Humoral-mediated cytotoxicity to rat pancreatic exocrine cells in serum of diabetes-prone BB/OK rats--predictive value for diabetes onset.
    Schröder D, Hehmke B, Klöting I, Schmidt S.
    Diabetes Res; 1993 Aug 05; 23(3):105-13. PubMed ID: 7712684
    [Abstract] [Full Text] [Related]

  • 14. Is there an autoimmune process in bone? Gene expression studies in diabetic and nondiabetic BB rats as well as BB rat-related and -unrelated rat strains.
    Klöting N, Follak N, Klöting I.
    Physiol Genomics; 2005 Dec 14; 24(1):59-64. PubMed ID: 16189279
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
    Schröder D, Wanka H, Hehmke B, Klöting I, Köhler E, Knospe S, Schmidt S.
    Diabetes Res; 1990 Sep 14; 15(1):27-32. PubMed ID: 2132197
    [Abstract] [Full Text] [Related]

  • 17. Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats.
    Kuttler B, Kauert C, Wanka H, Diamantstein T, Hahn HJ.
    J Autoimmun; 1996 Jun 14; 9(3):321-9. PubMed ID: 8816967
    [Abstract] [Full Text] [Related]

  • 18. Characterization of monoclonal islet cell reactive autoantibodies from the diabetic biobreeding (BB/OK) rat.
    Ziegler B, Witt S, Kohnert KD, Schlosser M, Augstein P, Michaelis D, Klöting I, Ziegler M.
    Acta Diabetol; 1993 Jun 14; 30(4):201-6. PubMed ID: 8180412
    [Abstract] [Full Text] [Related]

  • 19. Effect of serum from diabetes-prone BB/OK rats on neonatal rat pancreatic islets and islet cell suspensions.
    Schröder D, Hehmke B, Klöting I, Besch W.
    Exp Clin Endocrinol; 1989 May 14; 93(2-3):187-92. PubMed ID: 2673813
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic activity of sera from diabetic BB rats against BB rat islet--a functional study.
    Ziegler B, Klöting I, Besch W, Ziegler M, Hahn HJ.
    Diabetes Res; 1987 Feb 14; 4(2):67-72. PubMed ID: 3555954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.